Trials / Withdrawn
WithdrawnNCT02410421
e-PAT Neuromod Evaluation of Personalized rTMS for Resistant Depression
Validation of Individualized rTMS Protocol Using Non Invasive Functional Brain Imaging and Robotic Coil Placement in Resistant Depression: Comparison With Classical rTMS and tDCS
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Although repetitive trans-cranial magnetic stimulation (rTMS) is an effective therapy for resistant depression, it still fail to remit up to 70% of these patients. We hypothesize that personalizing the procedure using functional MRI to better select dysfunctional regions and robotic coil placement to stimulate these regions homogeneously, will increase its efficacy. Individualized rTMS will be compared to traditional rTMS procedure and to trans-cranial direct current stimulation (tDCS). In this small proof of principle study our primary outcome measure will be the correction of the MRI anomalies. Symptoms reduction and the proportion of remitters will be secondary outcome measurements.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Functional magnetic resonance imaging used to individualize rTMS protocol using robotic coil positioning |
Timeline
- Primary completion
- 2020-05-01
- Completion
- 2020-05-01
- First posted
- 2015-04-07
- Last updated
- 2016-01-05
Source: ClinicalTrials.gov record NCT02410421. Inclusion in this directory is not an endorsement.